Study ID: EV3 Durablilty PAS CP-1001

The US StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem Post Approval Study (DURABILITY PAS)


The purpose of this study is to collect information about how the ProtégéTM EverFlex¿ Stent System (EverFlex Stent), works in the treatment of superficial femoral and popliteal artery disease in the leg. The primary objective of this study is to confirm the long-term safety and effectiveness of the EverFlex¿ Self-Expanding Stent System through three years post-procedure.

Sioux Falls Region
Principal Investigator:
Greg Schultz, MD
Post Marketing


Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.

Back to Clinical Trials list